Vitaliy Katsenelson

Is Your Dividend Merely a ‘Shiny Object’ to Investors?
Investor Relations

Is Your Dividend Merely a ‘Shiny Object’ to Investors?

Coca Cola epitomizes a frequent truth: that the value of dividends paid by old, mature companies can be wiped out by stagnant revenue and profits.
By David McCann | February 17, 2020
Read More
Why Some of Today’s Corporate Powerhouses May Not Survive
Strategy

Why Some of Today’s Corporate Powerhouses May Not Survive

Will giants like General Motors and Walmart make the same mistake Nokia made? Or will they emulate Tesla and Amazon?
By David McCann | January 16, 2020
Read More
Uber’s IPO: Better Than You Thought
IPOs

Uber’s IPO: Better Than You Thought

While media reports proclaimed the ride-sharing service's initial public offering to be a failure, it really wasn't.
By David McCann | July 19, 2019
Read More
Big Health Care Companies Are Undervalued
Investor Relations

Big Health Care Companies Are Undervalued

McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
By David McCann | July 1, 2019
Read More
Is Value Investing Dead?
Investor Relations

Is Value Investing Dead?

Maybe not, but investors historically on the value side are now buying more stocks on the growth side of the market. But should they be?
By David McCann | June 7, 2019
Read More
Softbank’s Investment in WeWork: No Problem
Technology

Softbank’s Investment in WeWork: No Problem

The Japanese conglomerate's investment in a company whose CEO's business dealings are under fire won't derail its continuing success: Opinion.
By David McCann | April 18, 2019
Read More
Three Questions to Ask about Tesla
Investor Relations

Three Questions to Ask about Tesla

Will Elon Musk succeed with his strategy of wooing investors with promises for the future and one shiny new object after another?
By Vitaliy Katsenelson | August 1, 2018
Read More
So You Want To Know What the Market Will Do?
Investor Relations

So You Want To Know What the Market Will Do?

Forget it. No one knows what the stock market will do in the short term, and if someone says they do, they're a liar.
By Vitaliy Katsenelson | June 18, 2018
Read More
How Amazon Could Lose Its Health-Care Bid
Investor Relations

How Amazon Could Lose Its Health-Care Bid

The idea that the online retail-distribution giant could overtake large entrenched drug distributors like McKesson is far-fetched.
By Vitaliy Katsenelson | May 11, 2018
Read More